Morning Trend | ACOTEC-B continues to be sluggish, with a strong atmosphere of wait-and-see among major players

On January 15th, ACOTEC-B (6669.HK) maintained low trading volume throughout the day, with most major funds remaining on the sidelines. There was a general outflow of funds from the innovative drug and medical services sectors, and the industry overall lacked funding attention. From the market perspective, technical indicators remained in a horizontal fluctuation, with the Bollinger Bands refreshing extreme values, and mainstream algorithmic trading activities approaching a freezing point. There are currently no significant policy or merger and acquisition events to stimulate the industry, and the market is waiting for the next round of catalysts. If there are major events such as new drug registrations or mergers and acquisitions in the industry, it is expected to attract major funds back, but without any event background, both risks and opportunities remain unclear. It is recommended to participate only with a small position and to pay close attention to sudden information